1. Home
  2. SBFM vs WNW Comparison

SBFM vs WNW Comparison

Compare SBFM & WNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBFM
  • WNW
  • Stock Information
  • Founded
  • SBFM 2006
  • WNW 2015
  • Country
  • SBFM United States
  • WNW China
  • Employees
  • SBFM N/A
  • WNW N/A
  • Industry
  • SBFM Biotechnology: Pharmaceutical Preparations
  • WNW Catalog/Specialty Distribution
  • Sector
  • SBFM Health Care
  • WNW Consumer Discretionary
  • Exchange
  • SBFM Nasdaq
  • WNW Nasdaq
  • Market Cap
  • SBFM 6.5M
  • WNW 5.7M
  • IPO Year
  • SBFM N/A
  • WNW 2020
  • Fundamental
  • Price
  • SBFM $1.49
  • WNW $1.69
  • Analyst Decision
  • SBFM Strong Buy
  • WNW
  • Analyst Count
  • SBFM 1
  • WNW 0
  • Target Price
  • SBFM $15.00
  • WNW N/A
  • AVG Volume (30 Days)
  • SBFM 54.6K
  • WNW 15.8K
  • Earning Date
  • SBFM 08-12-2025
  • WNW 08-26-2025
  • Dividend Yield
  • SBFM N/A
  • WNW N/A
  • EPS Growth
  • SBFM N/A
  • WNW N/A
  • EPS
  • SBFM N/A
  • WNW 9.06
  • Revenue
  • SBFM $36,341,741.00
  • WNW $158,485.00
  • Revenue This Year
  • SBFM $32.20
  • WNW N/A
  • Revenue Next Year
  • SBFM $32.74
  • WNW N/A
  • P/E Ratio
  • SBFM N/A
  • WNW $0.19
  • Revenue Growth
  • SBFM 19.22
  • WNW N/A
  • 52 Week Low
  • SBFM $1.17
  • WNW $0.95
  • 52 Week High
  • SBFM $3.90
  • WNW $70.00
  • Technical
  • Relative Strength Index (RSI)
  • SBFM 51.16
  • WNW 40.81
  • Support Level
  • SBFM $1.35
  • WNW $1.66
  • Resistance Level
  • SBFM $1.52
  • WNW $1.82
  • Average True Range (ATR)
  • SBFM 0.08
  • WNW 0.09
  • MACD
  • SBFM 0.01
  • WNW -0.01
  • Stochastic Oscillator
  • SBFM 66.30
  • WNW 18.73

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

About WNW Meiwu Technology Company Limited

Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.

Share on Social Networks: